首页> 美国卫生研究院文献>Critical Care >Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected

【2h】

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected

机译：静脉输注新的羟乙基淀粉130 / 0.4（6％）在19位轻度至重度肾功能不全患者中的药代动力学和耐受性：终末半衰期和峰值浓度（Cmax）保持不变

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Critical Care
作者
C Jungheinrich; R Scharpf; M Wargenau; F Bepperling;
展开▼
作者单位

展开▼
年(卷),期 2001(5),Suppl 1
年度 2001
页码 P118
总页数 137
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献

1. Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (C_max)remain unaffected [J] . C Jungheinrich, R Scharpf, M Wargenau, Critical care : . 2001,第Suppla1期

机译：新的羟乙基淀粉130 / 0.4（6％）在19位轻度至重度肾功能不全患者中的药代动力学和耐受性：终末半衰期和峰值浓度（C _{max ）保持不变}
2. Pharmacokinetics and safety of 6?% hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500?ml solution. [J] . Michiaki Yamakage, Frank Bepperling, Manfred Wargenau, Journal of anesthesia . 2012,第6期

机译：单次输注500 µml溶液后，6？％羟乙基淀粉130 / 0.4在日本族裔健康男性志愿者中的药代动力学和安全性。
3. Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution [J] . Michiaki Yamakage, Frank Bepperling, Manfred Wargenau, Journal of Anesthesia . 2012,第6期

机译：一次输注500 ml溶液后6％羟乙基淀粉130 / 0.4在日本族裔健康男性志愿者中的药代动力学和安全性
4. Pharmacokinetics Tolerability and Safety of Murepavadin a Novel Antipseudomonal Antibiotic in Subjects with Mild Moderate or Severe Renal Function Impairment [O] . Glenn E. Dale, Atef Halabi, Marc Petersen-Sylla, 2018

机译：Murepavadin一种新型的抗假性抗生素在轻度中度或严重肾功能损害患者中的药代动力学耐受性和安全性
5. Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected [O] . Jungheinrich, C, Scharpf, R, Wargenau, M, 2001

机译：静脉输注新的羟乙基淀粉130 / 0.4（6％）在19位轻度至重度肾功能不全患者中的药代动力学和耐受性：终末半衰期和峰值浓度（Cmax）保持不变

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected

著录项

相似文献

相关主题

期刊订阅